New Risk • Dec 30
New major risk - Financial data availability The company has not reported any financial data. This is considered a major risk. With no or incomplete audited reported financial data, it is virtually impossible to assess the company's investment potential. Currently, the following risks have been identified for the company: Major Risks No financial data reported. Share price has been highly volatile over the past 3 months (20% average weekly change). Market cap is less than US$10m (€3.94m market cap, or US$4.64m). New Risk • Dec 01
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.7x net interest cover). Share price has been highly volatile over the past 3 months (19% average weekly change). Market cap is less than US$10m (€4.48m market cap, or US$5.20m). Minor Risk Latest financial reports are more than 6 months old (reported June 2024 fiscal period end). New Risk • May 21
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of French stocks, typically moving 18% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (13% operating cash flow to total debt). Share price has been highly volatile over the past 3 months (18% average weekly change). Earnings have declined by 56% per year over the past 5 years. Market cap is less than US$10m (€7.00m market cap, or US$7.93m). Reported Earnings • May 19
Full year 2024 earnings released Full year 2024 results: Revenue: €68.6m (up 29% from FY 2023). Net loss: €26.0k (down 105% from profit in FY 2023). Profit margin: 0% (down from 1.1% in FY 2023). Board Change • May 19
Less than half of directors are independent Following the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Director Damien Graton was the last independent director to join the board, commencing their role in 2023. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. 공시 • May 17
SAS Florentaise, Annual General Meeting, Jun 20, 2025 SAS Florentaise, Annual General Meeting, Jun 20, 2025. Location: grand patis, saint mars du desert France New Risk • Feb 21
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of French stocks, typically moving 10% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (10% average weekly change). Minor Risks High level of debt (104% net debt to equity). Latest financial reports are more than 6 months old (reported December 2023 fiscal period end). Market cap is less than US$100m (€18.5m market cap, or US$19.3m). New Risk • Oct 14
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (18% operating cash flow to total debt). Earnings have declined by 36% per year over the past 5 years. Minor Risks Latest financial reports are more than 6 months old (reported December 2023 fiscal period end). Share price has been volatile over the past 3 months (7.2% average weekly change). Market cap is less than US$100m (€50.3m market cap, or US$55.0m). Reported Earnings • Mar 31
First half 2024 earnings released First half 2024 results: €0.28 loss per share. Net loss: €2.27m (flat on 1H 2023). Valuation Update With 7 Day Price Move • Mar 27
Investor sentiment improves as stock rises 42% After last week's 42% share price gain to €3.20, the stock trades at a trailing P/E ratio of 46.9x. Average trailing P/E is 18x in the Chemicals industry in France. Valuation Update With 7 Day Price Move • Mar 01
Investor sentiment improves as stock rises 32% After last week's 32% share price gain to €2.38, the stock trades at a trailing P/E ratio of 34.9x. Average trailing P/E is 19x in the Chemicals industry in France. Valuation Update With 7 Day Price Move • Feb 15
Investor sentiment deteriorates as stock falls 18% After last week's 18% share price decline to €1.85, the stock trades at a trailing P/E ratio of 27.1x. Average trailing P/E is 18x in the Chemicals industry in France. New Risk • Nov 08
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of French stocks, typically moving 7.1% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (14% operating cash flow to total debt). Revenue has declined by 14% over the past year. Minor Risks Share price has been volatile over the past 3 months (7.1% average weekly change). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (1.0% net profit margin). Market cap is less than US$100m (€25.5m market cap, or US$27.4m). Reported Earnings • Nov 02
Full year 2023 earnings released: EPS: €0.07 (vs €0.49 in FY 2022) Full year 2023 results: EPS: €0.07 (down from €0.49 in FY 2022). Revenue: €54.5m (down 14% from FY 2022). Net income: €562.0k (down 80% from FY 2022). Profit margin: 1.0% (down from 4.5% in FY 2022). Valuation Update With 7 Day Price Move • Nov 01
Investor sentiment deteriorates as stock falls 19% After last week's 19% share price decline to €4.90, the stock trades at a trailing P/E ratio of 14.3x. Average trailing P/E is 13x in the Chemicals industry in France. New Risk • Sep 22
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2022. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (7.9% operating cash flow to total debt). High level of non-cash earnings (21% accrual ratio). Minor Risks Latest financial reports are more than 6 months old (reported June 2022 fiscal period end). Market cap is less than US$100m (€54.0m market cap, or US$57.6m). New Risk • Sep 06
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2022. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (7.9% operating cash flow to total debt). High level of non-cash earnings (21% accrual ratio). Minor Risks Latest financial reports are more than 6 months old (reported June 2022 fiscal period end). Market cap is less than US$100m (€61.2m market cap, or US$65.6m).